| Ytd | -77.98% | |
| 1y | -95.48% |
| Open | 0.60 | Prev Close | 0.60 | Low | 0.59 | High | 0.62 | Mkt Cap | 464.38K |
| Vol | 106.92K | Avg Vol | 644.74K | EPS | -10.61 | P/E | -0.06 | Forward P/E | -0.86 |
| Beta | 1.75 | Short Ratio | 0.98 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.59 | 200-d Avg | 2.83 | 1yr Est | 3.85 |
AEMD News
Second cohort findings consistent with previously reported observations; independent statistical ana
Second cohort findings consistent with previously reported observations; independent statistical ana
Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to
SAN DIEGO, July 6, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional
Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst
Australian oncology study advances into Cohort 3 as enrollment continues Entered the third and final
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic
https://x.com/PatentGrants/status/2061537506194346238?s=20https://patentcenter.uspto.gov/application
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro
Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to
SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - March 24, 2026) - Investorideas.c
SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage bio
SAN DIEGO, March 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq
The Company invites individual and institutional investors, as well as advisors and analysts with an
Aethlon invites individual and institutional investors as well as advisors and analysts, to attend i
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript
Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conf
SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic
Aethlon Medical, Inc. (NASDAQ: AEMD - Get Free Report)'s share price passed below its 200-day moving
Aethlon Medical, Inc. (NASDAQ: AEMD - Get Free Report)'s share price crossed below its two hundred d
SAN DIEGO , Dec. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq:
